SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Aethlon Medical Presents Hemopurifier Data At American Association for Cancer Research 2020 Annual Meeting

SAN DIEGO, June 22, 2020 /PRNewswire/ --Aethlon Medical, Inc. (NASDAQ:AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, today

Benzinga · -

SAN DIEGO, June 22, 2020 /PRNewswire/ --Aethlon Medical, Inc. (NASDAQ:AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, today released positive ex vivo data demonstrating the ability of a laboratory version of the Company's Hemopurifier® to capture tumor-derived exosomes in several forms of cancer. The data were presented in e-poster format by Dr. Annette Marleau, the Company's Senior Director of Research, at the American Association for Cancer Research (AACR) Virtual Annual Meeting II, on June 22, 2020.